Paula Aldaz holds a degree in Health Biology and Biochemistry from the University of Navarra. She obtained her PhD in Neuroscience from the University of the Basque Country (UPV/EHU), conducting her thesis research in the Department of Cellular Oncology at the Biodonostia Health Research Institute. Currently, she is a Postdoctoral Researcher of the Cancer Signaling group at the Navarrabiomed-FMS Biomedical Research center, within the Navarra Health Research Insitute (IdisNA). Her research career is focused on cancer research, specifically on Glioblastoma, which represents the most malignant brain tumor.
Enrique Santamaria obtained a PhD degree in Biochemistry (2005) from the Department of Hepatology and Gene Therapy, University of Navarra (UNAV). After this, he was a postdoc in the group of Fernando Corrales (2006-10) at the Center for Applied Medical Research (CIMA, Spain), gaining extensive knowledge in proteomic strategies to improve the potency and safety of HSV-1-based oncolytic vectors. In 2011, he joined the Navarrabiomed Research Center as the Head of the Clinical Neuroproteomics Unit. His interest is focused on the characterization of mechanisms associated with brain function and neurodegeneration using olfactory multi-omic approaches, in order to establish novel biomarkers and future intranasal therapies. He is a member of the Spanish Proteomics Network, European Proteomics Association (EuPA), Spanish Olfactory Network (ROE), Global Consortium for Chemosensory Research (GCCR), and an active researcher in the international Human Brain Proteome Project.
